Catheter-based renal sympathetic denervation for resistant hypertension: Durability of blood pressure reduction out to 24 months

Henry Krum; Neil Barman; Markus Schlaich; Paul Sobotka; Murray Esler; Felix Mahfoud; Michael Bohm; Mark Dunlap

doi:10.1161/?HYPERTENSIONAHA.110.163014

Catheter-based renal sympathetic denervation for resistant hypertension: Durability of blood pressure reduction out to 24 months

Henry Krum, Neil Barman, Markus Schlaich, Paul Sobotka, Murray Esler, Felix Mahfoud, Michael Bohm, Mark Dunlap

Epidemiology and Preventive Medicine Alfred Hospital

Research output: Contribution to journal › Article › Research › peer-review

765 Citations (Scopus)

Abstract

Renal sympathetic hyperactivity is seminal in the maintenance and progression of hypertension. Catheter-based renal sympathetic denervation has been shown to significantly reduce blood pressure (BP) in patients with hypertension. Durability of effect beyond 1 year using this novel technique has never been reported. A cohort of 45 patients with resistant hypertension (systolic BP a?Y160 mm Hg on a?Y3 antihypertension drugs, including a diuretic) has been originally published.

Original language	English
Pages (from-to)	911 - 917
Number of pages	7
Journal	Hypertension
Volume	57
Issue number	5
DOIs	https://doi.org/10.1161/?HYPERTENSIONAHA.110.163014
Publication status	Published - 2011

Access to Document

10.1161/?HYPERTENSIONAHA.110.163014

Cite this

@article{b3fb99085a194ba8aac9be715dcfbf48,

title = "Catheter-based renal sympathetic denervation for resistant hypertension: Durability of blood pressure reduction out to 24 months",

abstract = "Renal sympathetic hyperactivity is seminal in the maintenance and progression of hypertension. Catheter-based renal sympathetic denervation has been shown to significantly reduce blood pressure (BP) in patients with hypertension. Durability of effect beyond 1 year using this novel technique has never been reported. A cohort of 45 patients with resistant hypertension (systolic BP a?Y160 mm Hg on a?Y3 antihypertension drugs, including a diuretic) has been originally published.",

author = "Henry Krum and Neil Barman and Markus Schlaich and Paul Sobotka and Murray Esler and Felix Mahfoud and Michael Bohm and Mark Dunlap",

year = "2011",

doi = "10.1161/?HYPERTENSIONAHA.110.163014",

language = "English",

volume = "57",

pages = "911 -- 917",

journal = "Hypertension",

issn = "0194-911X",

publisher = "American Heart Association",

number = "5",

}

TY - JOUR

T1 - Catheter-based renal sympathetic denervation for resistant hypertension: Durability of blood pressure reduction out to 24 months

AU - Krum, Henry

AU - Barman, Neil

AU - Schlaich, Markus

AU - Sobotka, Paul

AU - Esler, Murray

AU - Mahfoud, Felix

AU - Bohm, Michael

AU - Dunlap, Mark

PY - 2011

Y1 - 2011

N2 - Renal sympathetic hyperactivity is seminal in the maintenance and progression of hypertension. Catheter-based renal sympathetic denervation has been shown to significantly reduce blood pressure (BP) in patients with hypertension. Durability of effect beyond 1 year using this novel technique has never been reported. A cohort of 45 patients with resistant hypertension (systolic BP a?Y160 mm Hg on a?Y3 antihypertension drugs, including a diuretic) has been originally published.

AB - Renal sympathetic hyperactivity is seminal in the maintenance and progression of hypertension. Catheter-based renal sympathetic denervation has been shown to significantly reduce blood pressure (BP) in patients with hypertension. Durability of effect beyond 1 year using this novel technique has never been reported. A cohort of 45 patients with resistant hypertension (systolic BP a?Y160 mm Hg on a?Y3 antihypertension drugs, including a diuretic) has been originally published.

UR - http://hyper.ahajournals.org/content/57/5/911.full.pdf+html

U2 - 10.1161/?HYPERTENSIONAHA.110.163014

DO - 10.1161/?HYPERTENSIONAHA.110.163014

M3 - Article

SN - 0194-911X

VL - 57

SP - 911

EP - 917

JO - Hypertension

JF - Hypertension

IS - 5

ER -

Catheter-based renal sympathetic denervation for resistant hypertension: Durability of blood pressure reduction out to 24 months

Abstract

Access to Document

Other files and links

Cite this